Related references
Note: Only part of the references are listed.Intracellular glutathione-depleting polymeric micelles for cisplatin prodrug delivery to overcome cisplatin resistance of cancers
Yu Han et al.
JOURNAL OF CONTROLLED RELEASE (2018)
miR-25-3p reverses epithelial-mesenchymal transition via targeting Sema4C in cisplatin-resistance cervical cancer cells
Jing Song et al.
CANCER SCIENCE (2017)
Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target
U. Saini et al.
ONCOGENE (2017)
miR-455 inhibits breast cancer cell proliferation through targeting CDK14
Bing Wang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine
Chiranjib Chakraborty et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line
Jian-Huang Li et al.
TUMOR BIOLOGY (2016)
Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway
Wei Xu et al.
CANCER LETTERS (2015)
miR-216a may inhibit pancreatic tumor growth by targeting JAK2
Bao-hua Hou et al.
FEBS LETTERS (2015)
Inhibition of cisplatin-resistance by RNA interference targeting metallothionein using reducible oligo-peptoplex
Jong-Hwan Lee et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer
Yan Gao et al.
ONCOTARGET (2015)
Predicting effective microRNA target sites in mammalian mRNAs
Vikram Agarwal et al.
ELIFE (2015)
MicroRNA Processing and Human Cancer
Masahisa Ohtsuka et al.
JOURNAL OF CLINICAL MEDICINE (2015)
MicroRNA silencing for cancer therapy targeted to the tumour microenvironment
Christopher J. Cheng et al.
NATURE (2015)
MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer
Nicolai A. Schultz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2
Siliang Wang et al.
ONCOLOGY REPORTS (2014)
A Ten-MicroRNA Signature Identified from a Genome-Wide MicroRNA Expression Profiling in Human Epithelial Ovarian Cancer
Lin Wang et al.
PLOS ONE (2014)
Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly
Xi'an Zhang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2013)
MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer
Hongping Xia et al.
HEPATOLOGY (2013)
Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells
David J. Mulholland et al.
CANCER RESEARCH (2012)
Prognostic significance of NF-κB in Middle Eastern diffuse large B cell lymphoma and efficacy of NF-κB inhibition as a viable therapeutic target
Prashant Bavi et al.
CANCER RESEARCH (2011)
miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma
Min Deng et al.
JOURNAL OF CELL SCIENCE (2011)
Secondary Somatic Mutations Restoring BRCA1/2 Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas
Barbara Norquist et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Rethinking ovarian cancer: recommendations for improving outcomes
Sebastian Vaughan et al.
NATURE REVIEWS CANCER (2011)
STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to Cancer
Dimitrios Iliopoulos et al.
MOLECULAR CELL (2010)
Nanoparticles Modified With Tumor-targeting scFv Deliver siRNA and miRNA for Cancer Therapy
Yunching Chen et al.
MOLECULAR THERAPY (2010)
Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma
S. L. Cooke et al.
ONCOGENE (2010)
Plasma miR-216a as a potential marker of pancreatic injury in a rat model of acute pancreatitis
Xiang-Yu Kong et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
BCL9 Promotes Tumor Progression by Conferring Enhanced Proliferative, Metastatic, and Angiogenic Properties to Cancer Cells
Mala Mani et al.
CANCER RESEARCH (2009)
Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model
Janaiah Kota et al.
CELL (2009)
Kruppel-like factor 12 plays a significant role in poorly differentiated gastric cancer progression
Yu Nakamura et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Maintenance Therapy for Ovarian Cancer: Of Helsinki and Hippocrates
William Patrick McGuire
JOURNAL OF CLINICAL ONCOLOGY (2009)
MicroRNA expression profiling in human ovarian cancer:: miR-214 induces cell survival and cisplatin resistance by targeting PTEN
Hua Yang et al.
CANCER RESEARCH (2008)
MicroRNA Expression and Identification of Putative miRNA Targets in Ovarian Cancer
Neetu Dahiya et al.
PLOS ONE (2008)
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer
Lin Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk
Peter Broderick et al.
NATURE GENETICS (2007)
MicroRNA signatures in human ovarian cancer
Marilena V. Iorio et al.
CANCER RESEARCH (2007)
MITF: master regulator of melanocyte development and melanoma oncogene
Carmit Levy et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line
S Lee et al.
GYNECOLOGIC ONCOLOGY (2005)
MODBASE, a database of annotated comparative protein structure models, and associated resources
U Pieper et al.
NUCLEIC ACIDS RESEARCH (2004)
PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells
S Sun et al.
JOURNAL OF GENERAL VIROLOGY (2002)
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
GL Niu et al.
ONCOGENE (2002)
Share Paper
